12 April 2023
Ferrexpo plc
("Ferrexpo" or the "Company" or the "Group")
Total Voting Rights
In accordance with the Disclosure Guidance and Transparency Rules (the 'Rules'), Ferrexpo plc (LSE: FXPO) confirms that, as at 31 March 2023, its issued share capital consisted of 613,967,956 ordinary shares of 10 pence each of which 15,830,814 ordinary shares are held in treasury.
Therefore, the total number of voting rights in Ferrexpo plc is 598,137,142.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Ferrexpo plc under the Rules.
For further information, please contact:
Ferrexpo: |
||
Rob Simmons |
+44 207 389 8305 |
|
Tavistock: |
||
Jos Simson Gareth Tredway |
+44 207 920 3150 +44 7785 974 264 |
About Ferrexpo:
Ferrexpo is a Swiss headquartered iron ore company with assets in Ukraine and a premium listing on the London Stock Exchange in the FTSE 250 index (ticker FXPO). The Group produces high grade iron ore pellets, which are a premium product for the global steel industry and enable reduced carbon emissions and increased productivity for steelmakers when the Group's iron ore pellets are converted into steel, compared to more commonly traded forms of iron ore. Ferrexpo's operations have been supplying the global steel industry for over 50 years, and in 2022 the Group produced 6.1 million tonnes of iron ore pellets, despite the war in Ukraine. Historically, Ferrexpo has been the world's third largest exporter of pellets to the global steel industry, recently having a market share of approximately 9% in 2021. The Group has a global customer base comprising of premium steel mills around the world, which includes steel mills in Austria, Germany, Japan, South Korea, Taiwan, China, Slovakia, the Czech Republic, Turkey, Vietnam and America. For further information, please visit www.ferrexpo.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDTVRUUUOROVUSAAR
Supplied Euroland.com - Privacy Policy